Table 4 HPV prevalence in anogenital cancer
From: Incidence and cost of anal, penile, vaginal and vulvar cancer in Denmark
HPV prevalence (% of cancers) | Prevalence (% of HPV-positive cancers) | |||
|---|---|---|---|---|
HPV 16 | HPV 18 | HPV 16/18*** | ||
Anal cancer* | 84.3 | 87.1 | 6.2 | 93.3 |
Penile cancer** | 46.7 | 60.2 | 13.4 | 73.6 |
Vaginal cancer* | 69.9 | 76.8 | 10.9 | 87.7 |
Vulvar cancer* | 40.4 | 79.7 | 10.9 | 90.6 |